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Edited by Takashi GojoboriAbstract The vertebrate transcription factor CTCF is not only
involved in transcriptional activation, insulation and genomic
imprinting, but also in transcriptional repression. Sequence
motifs mediating these activities have not been identiﬁed so far.
We have mapped a short repression motif to residues 150–170
within the N-terminal domain of CTCF. This motif is active in
HeLa, HEK293 and COS-7 cell lines where it is both suﬃcient
and necessary for silencing either an SV40-, or a CMV-
enhancer. It also represses the basal activity of an SV40 core
promoter. Since this autonomous repression motif displays no
sequence similarity to any other regulatory protein, it represents
a yet unknown co-repressor recruiting motif.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The transcription factor CTCF is not only involved in
enhancer blocking, but also in transcriptional activation,
imprinting of genomic information and in various human
malignancies as a putative tumor suppressor [1]. It further
participates in transcriptional repression of the chicken lyso-
zyme gene locus [2] and the chicken, mouse and human myc
loci [3]. The chicken CTCF protein consists of 728 aa and has
been divided into three domains: an N-terminal domain
spanning the ﬁrst 267 aa, a central domain comprising 11
zinc-ﬁngers and a C-terminal domain ranging from aa 578 to
728 [3]. As fusions of either domain to Gal4 led to repression
of reporter gene activity in various cell lines [3,4], autono-
mous repression domains seem to be distributed throughout
the protein. Co-precipitation experiments identiﬁed SIN3A
[4], YB1 [5], nucleophosmin and CTCF itself [6] as interac-
tion partners. The presence of SIN3A, which is part of a
large co-repressor complex containing HDAC1 and HDAC2
[7], suggests that transcriptional repression by CTCF is* Corresponding author. Fax: +49-9131-8528082.
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doi:10.1016/j.febslet.2004.07.027mediated by histone deacetylation. Others, however, were
unable to conﬁrm an association of CTCF with HDAC1 and
HDAC2 in human MCF-7 breast cancer cells [8]. So far, no
further interaction partners of CTCF have been published
nor have repression motifs within CTCF been mapped and
characterized.
We have analyzed subdomains of CTCF for repression ac-
tivity in a double transient, doxycycline (dox) dependent en-
hancer silencing assay. We mapped repression activity to an
element spanning residues CTCF(150–170) in HeLa cells. This
motif displays no obvious sequence similarity to any other
regulatory protein. Furthermore, it is both necessary and
suﬃcient for CTCF mediated repression of enhancer activity in
various cell lines and also represses the activity of a core
promoter.2. Materials and methods
2.1. Construction of reporter plasmids
All reporter plasmids are based on the pGL3 vector series (PRO-
MEGA). The plasmid pWHE206 encodes a luciferase gene under
control of an SV40 promoter/enhancer with (tetO)7 elements ﬂanking
the enhancer (Ameres et al., submitted). Introduction of DNA
spacers into pWHE206 was carried out as follows: A unique EcoRV
restriction site was introduced 30 to the PstI site with the primer
‘‘EcoRV-SV40enh’’ (GTGGTAAACTGCAGAAGGATATCTGAA-
CGATGGAGCGG). 500 bp spacer fragments were created by di-
gesting pUHD16-1 [9] with either BclI/Eco47III or BclI/ClaI. Blunt
ends were generated using T4-DNA-Polymerase. These spacer frag-
ments were integrated into the blunt ended restriction site BamHI or
EcoRV, respectively, resulting in pWHE295. A wild-type (tetO)7 box
was ampliﬁed from pUHC13-3 [9] and inserted into the BglII site of
pGL3-Promoter resulting in pWHE248. pWHE279 was constructed
as follows: The hCMV core promoter (+75/)53) [9] was ampliﬁed
from pWHE120(sB) [10] and introduced into pGL3-Promoter using
BglII and NcoI restriction sites, thereby replacing the SV40 core
promoter. The (tetO)7 element was isolated from pWHE201 and
introduced into the BglII site. The pCMV enhancer ()54/)675) [9]
element was ampliﬁed from pWHE120(sB) using the primers ‘‘CMV-
SalI(-54)’’ and ‘‘CMV-PstI(full)’’ and was introduced into the XhoI
site resulting in pWHE279.
2.2. Construction of Tet-transregulators
The coding sequence for full length CTCF(2–728) was ampliﬁed
from pBSKII-CTCF-FL(2–728) and inserted into pWHE120(sB) [10]
using restriction sites for NgoMIV and BglII, resulting in pWHE210.
The sc tetR allele was excised from pWHE120(sB + B) [10] and in-
troduced into pWHE210 using the SpeI and NgoMIV sites, thereby
replacing tetR resulting in pWHE219. The coding sequences of all
CTCF subdomains were ampliﬁed by PCR or overlap extension PCR
from pBSKII-CTCF-FL(2–728) and inserted into pWHE219 usingblished by Elsevier B.V. All rights reserved.
Fig. 1. Characterization of CTCF-domains in an SV40-based en-
hancer-silencing assay. HeLa cells were transiently transfected with
pGL3-Promoter, lacking the SV40-enhancer (E) and tet operators to
determine unenhanced luciferase activity, or pWHE295 carrying a
luciferase gene (gray arrow) under control of an SV40 core promoter
(small black arrow) and an SV40-enhancer ﬂanked with (tetO)7 ele-
ments (array of seven black boxes). pWHE295 was cotransfected with
plasmids coding for sc TetR-CTCF, -CTCF(267–728), -CTCF(2–67),
-CTCF(2–265/577–728), -CTCF(2–265) or sc TetR*. A schematic view
of the transfected transregulators is depicted. Repression factors are
indicated next to the bars.
L. Drueppel et al. / FEBS Letters 572 (2004) 154–158 155restriction sites for NgoMIV and AgeI, thereby replacing the
CTCF(2–728) allele.
The sequences of the oligonucleotides used and the plasmids con-
structed in this study are available upon request.
2.3. Transient transfections
Transfection of HeLa, HEK293 or COS-7 cells were performed with
PerFectinTM according to the instructions of the producer (PEQLAB).
The DNA mix used to examine the regulatory properties of diﬀerent
regulator/reporter combinations contained 400 ng of pUHD16-1 [9]
constitutively expressing b-galactosidase to monitor transfection eﬃ-
ciency, 100 ng pGL3-Promoter or equimolar amounts of other reporter
plasmids, 25 ng of the regulator plasmid control pWHE355, coding for
sc TetR* lacking a regulatory domain (Ameres et al., submitted), or
equimolar amounts of other regulator expressing plasmids and
pWHE121 [10] as non-speciﬁc DNA to a total amount of 1 lg per well.
After 4 h incubation, transfection reactions were stopped by adding 1
ml of D-MEM medium supplemented with 20% FBS. For induction,
dox (Sigma) was added to a ﬁnal concentration of 1 or 5 lg/ml.
2.4. Luciferase assay
Cells were harvested after 24 h incubation and lysed with 100 ll of 25
mM Tris-phosphate, 2 mM EDTA (pH 8.0), 5% glycerol, 1% Triton X-
100 and 20 mM DTT. A 30 ll aliquot was used to determine luciferase
activity in 100 mM potassium-phosphate-buﬀer (pH 7.8) containing 15
mM magnesium-sulfate, 5 mM ATP and 0.18 mM D-Luciferin (Bo-
ehringer). Luciferase activity was normalized for protein content (Bio-
Rad) and b-galactosidase activity [11] and represented by the means of
triplicate samples with standard deviation given in corrected light units
(corr. RLU) per lg of total cell protein.
2.5. Western blot analysis of transregulators in HeLa cells
20 lg total protein from cell extracts prepared for the luciferase
assays was separated on a Novex 4–12% precast Tris-Glycine poly-
acrylamide (PAA) gradient gel (Invitrogen) and transferred to a
polyvinyldiﬂuoride membrane (Amersham). The membrane was
blocked with I-Block (Tropix). A polyclonal TetR serum from rabbit
(laboratory stock) was used to detect Tet-transregulators. Signal in-
tensities were normalized to the b-actin signals (Sigma). Bound anti-
bodies were visualized using the ECL Plus kit (Amersham).3. Results
3.1. The N-terminal domain of CTCF harbors repression
activity
A transient test assay based on components of the Tet
system (reviewed in [12]) was constructed to determine if
dox-dependent CTCF binding is capable of silencing an SV40-
enhancer. The assay consists of two plasmids, one containing a
dox-dependent reporter gene and the other constitutively
expressing a TetR-based transregulator.
The reporter plasmid pWHE295 encodes a luciferase re-
porter gene under control of an SV40-promoter which is
activated by an SV40-enhancer located 2 kb downstream
from it. Since we use covalently closed plasmids in our assay,
the enhancer is also located 2.8 kb upstream of the promoter.
In order to silence this enhancer in a dox-dependent manner,
it was consequently ﬂanked with heptamerized tet operators
[9]. To rule out enhancer-silencing by ‘‘quenching’’ [13], 500
bp spacer elements were inserted between the SV40-enhancer
and the (tetO)7 elements. The regulator plasmids encode dox-
controlled transregulators, which consist of full length (728
aa) or truncated versions of CTCF [4,14] (Fig. 1) fused to the
C-terminal end of sc TetR (442 aa) [10]. This setup fuses a
single regulatory domain to a monomerized TetR, the DNA-
binding and eﬀector-responding unit. This enables us to
evaluate the activity of an isolated domain without potential
interference from the presence of a nearby second identicaldomain, as is the case in a setup using the Gal4 DNA
binding domain. This is noteworthy since CTCF interacts
with itself [6,15]. We additionally deleted the zinc-ﬁnger
domain as the region of interaction between CTCF and the
co-repressor SIN3A [4]. Also, an N-terminal aa motif
CTCF(2–67) that harbors a barrier element active in Sac-
charomyces cerevisiae was analyzed [14]. These TetR-based
transregulators bind with high speciﬁcity and aﬃnity to the
tetO elements of the reporter plasmid and, if they contain an
active regulatory domain, will silence enhancer activity. Ad-
dition of dox leads to a conformational change in the TetR
moiety resulting in the loss of tetO binding and subsequent
restoration of enhancer-mediated reporter gene expression.
Transregulator expressing plasmids were transiently cotrans-
fected with pWHE295 in HeLa cells (Fig. 1). In this experi-
ment, the three transregulators carrying an entire N-terminal
domain of CTCF silence an SV40-enhancer in a dox-depen-
dent manner. Since Western blot analysis shows that all
CTCF-based transregulators are present (data not shown),
we attribute repression activity solely to the N-terminal
domain, excluding residues 2–67.
3.2. Mapping a repression motif within the N-terminal domain
of CTCF
As the ﬁrst 67 aa of the N-terminal domain do not repress
luciferase activity, the N-terminal domain was further char-
acterized in HeLa cells by fusing the sections CTCF(2–190),
CTCF(130–265) and CTCF(130–190) to sc TetR. All three
subdomains repress luciferase activity in a dox-dependent
manner similar to full length CTCF or the isolated N-ter-
minal domain. The repression motif was thus narrowed down
to aa 130–190 of CTCF. Next, CTCF(130–170), CTCF(150–
190), CTCF(130–150), CTCF(150–170) and CTCF(170–190)
were fused to sc TetR and analyzed. CTCF(130–170),
CTCF(150–190) and CTCF(150–170) repress luciferase
Fig. 3. Deletion of CTCF(150–170) out of the N-terminal domain of
CTCF results in an inactive transregulator. HeLa cells were transiently
transfected with pGL3-Promoter, lacking the SV40-enhancer (E) and
tet operators to determine unenhanced luciferase activity, or
pWHE295 carrying a luciferase gene (gray arrow) under control of an
SV40 core promoter (small black arrow) and an SV40-enhancer
ﬂanked with (tetO)7 elements (array of seven black boxes). pWHE295
was cotransfected with plasmids coding for sc TetR-CTCF, -CTCF(2–
265), -CTCF(150–190), -CTCF(2–149/171–265) or sc TetR*. A sche-
matic view of the transfected transregulators is depicted. Repression
factors are indicated next to the bars.
Fig. 2. Identiﬁcation of a 21 aa repression motif within the N-terminal
domain of CTCF. (A) HeLa cells were transiently transfected with
pGL3-Promoter, lacking the SV40-enhancer (E) and tet operators to
determine unenhanced luciferase activity, or pWHE295 carrying a
luciferase gene (gray arrow) under control of an SV40 core promoter
(small black arrow) and an SV40-enhancer ﬂanked with (tetO)7 ele-
ments (array of seven black boxes). pWHE295 was cotransfected with
plasmids coding for sc TetR-CTCF, -CTCF(2–265), -CTCF(130–190),
-CTCF(130–170), -CTCF(150–190), -CTCF(130–150), -CTCF(150–
170), -CTCF(170–190) or sc TetR*. A schematic view of the trans-
fected transregulators is depicted. Repression factors are indicated next
to the bars. (B) Expression of CTCF-based transregulators in tran-
siently transfected HeLa cells. Crude cell lysates from transiently
transfected HeLa cells were separated on a 4–12% gradient PAA gel
and subjected to Western blot analysis. The blot was probed with anti-
TetR or anti-b-actin antibodies.
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fold repression of luciferase activity was measured for
CTCF(130–150), CTCF(170–190) and the sc TetR* control.
Western blot analysis of crude cell lysates from the transient
transfection (Fig. 2B) shows that all CTCF-based transregu-
lators except sc TetR-CTCF are present at similar levels. We
were able to detect sc TetR-CTCF in Western blots by
loading twice the amount of total protein in combination
with long exposure times (data not shown). Lack of expres-
sion is thus not responsible for the failure of the respective
transregulators to repress luciferase expression in the tran-
sient transfection experiment. We then deleted the aa 150–170
segment from the N-terminal domain of CTCF. The resulting
construct was inactive, like the sc TetR* control (Fig. 3).
Taken together, the 21 aa motif CTCF(150–170) is both
suﬃcient and necessary for silencing activated transcription
from an SV40-enhancer in HeLa cells.
3.3. CTCF(150–170) represses the activity of an SV40 core
promoter
We then targeted CTCF based transregulators to a promoter
proximal (tetO)7 element in order to test their ability to repress
the basal activity of an SV40 core promoter (Fig. 4A). In the
absence of dox, the isolated N-terminal domain and
CTCF(150–170) repress luciferase activity to levels below thebackground represented by pWHE248 alone. Less than 2-fold
repression of luciferase activity was determined for
CTCF(170–190) and the sc TetR* control. Upon administra-
tion of dox, repression levels are relieved to the level repre-
sented by pWHE248. Therefore, the 21 aa long, N-terminal
repression motif CTCF(150–170) is not only limited to si-
lencing an SV40-enhancer, but also represses the activity of an
SV40 core promoter.
3.4. CTCF(150–170) represses the activity of a CMV-enhancer
in various cell lines
Since the N-terminal domain of CTCF was attributed to
harbor cell-type speciﬁc repression activity [4], we further
tested CTCF based transregulators in transiently transfected
HEK293 and COS-7 cells. For this, we used a CMV-based
reporter plasmid to determine the ability of CTCF subdo-
mains to repress a stronger enhancer (Fig. 4B). In this ex-
periment full length CTCF, the isolated N-terminal domain,
CTCF(130–190) and CTCF(150–170) repress the proximal
CMV-enhancer in both cell lines in a dox-dependent manner.
Taken together, the N-terminal repression motif CTCF(150–
170) silences activated transcription from a distal SV40-, or a
proximal CMV-enhancer, represses basal transcription of an
SV40 core promoter and is active in HeLa, HEK293 and
COS-7 cell lines.4. Discussion
The multivalent transcription factor CTCF not only par-
ticipates in transcriptional activation and enhancer blocking,
but also in transcriptional repression. Gal4-based CTCF fu-
sions revealed several autonomous regulatory domains, some
of which act in a cell-type speciﬁc manner (for reviews see
[1,16]). CTCF binds its cognate target sites, associated with
diverse CTCF activities, by combinatorial use of the eleven
zinc ﬁngers possibly resulting in alternative protein confor-
Fig. 4. (A) CTCF(150–170) represses the activity of an SV40 core
promoter. HeLa cells were transiently cotransfected with pWHE248,
carrying a luciferase gene (gray arrow) under control of an SV40 core
promoter (small black arrow) and a promoter proximal (tetO)7 ele-
ment (array of seven black boxes), and plasmids coding for sc TetR-
CTCF(2–265), -CTCF(150–170), -CTCF(170–190) or sc TetR*. A
schematic view of the transfected transregulators is depicted. Repres-
sion factors are indicated next to the bars. (B) The identiﬁed repression
motifs are active in HEK293 and COS-7 cells. HEK293 and COS-7
cells were transiently cotransfected with pWHE279, carrying a lucif-
erase gene (gray arrow) under control of a CMV core promoter (small
white arrow)/enhancer (Enh) interspersed with a (tetO)7 element (array
of seven black boxes), and plasmids coding for sc TetR-CTCF, sc
TetR-CTCF(2–265), sc TetR-CTCF(130–190), sc TetR-CTCF(150–
170), sc TetR-CTCF(170–190), sc TetR-CTCF(2–149/171–265) or sc
TetR*. A schematic view of the transfected transregulators is depicted.
Repression factors are indicated next to the bars.
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[1,14]. By fusing subdomains of CTCF to sc TetR, we were
able to characterize the activity of single, deﬁned CTCF
subdomains without interference from a second identical
domain nearby, as might be the case in a setup using dimeric
Gal4 DNA binding domains. This is particularly noteworthy,
since CTCF can interact with itself [6,15]. Using our transient
SV40-based enhancer silencing assay, we mapped repression
activity to the N-terminal domain of CTCF (Fig. 1) [3,4]. In
contrast, we did not observe repression activity in the zinc
ﬁnger and C-terminal domains [3,4] in HeLa cells.
The ﬁrst 65 aa of CTCF display barrier activity in yeast [14],
but failed to repress luciferase activity in our assay (Fig. 1).
However, recent studies have demonstrated that many pro-
teins, including the isolated DNA-binding domain of the
prokaryotic repressor LexA, exhibit barrier function in yeast
[17,18]. Moreover, CTCF does not display barrier activity in
vertebrates [19,20]. Utilizing our enhancer silencing assay in
HeLa cells, we instead mapped repression activity to the 21 aa
motif CTCF(150–170) (Fig. 2). This motif is suﬃcient andnecessary for silencing a distal SV40- (Fig. 3), as well as a
proximal CMV-enhancer (Fig. 4B). Moreover, it represses the
basal activity of an SV40 core promoter (Fig. 4A) and is active
in HeLa, HEK293 and COS-7 cell lines (Fig 4B), demon-
strating that this 21 aa element represents a bona ﬁde auton-
omous repression motif. Except for the ﬁrst residue, this
element is identical in the CTCF proteins from Xenopus,
mouse, chicken and man. In eukaryotes, transcription factors
frequently mediate repression by recruiting co-repressors via
short amino acid motifs [21–23], like ‘‘Pro–Xaa–Asp–Leu–
Ser’’, a motif recognized by the co-repressor family of ‘‘C-
terminal binding proteins’’ [24] or the four amino acid motif
‘‘Trp–Arg–Pro–Trp’’ that recruits ‘‘Transducin-like Enhancers
of Split’’ as co-repressors [25]. Since BLAST or FASTA
analysis of CTCF(150–170) revealed no identical clusters to
those motifs or to any other regulatory proteins (data not
shown), we suggest that we have identiﬁed a yet unknown co-
repressor recruiting motif.
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